ObsEva SA: ObsEva Annual General Meeting 2022 : vimarsana.co

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland and Boston, MA - April 7, 2022 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing

Related Keywords

United States , United Kingdom , Plan Les Ouates , Genè , Switzerland , Boston , Massachusetts , Geneva , Canada , West Island , Edinburgh , City Of , America , Scotland , Swiss , Annette Clancy , Anne Vanlent , Franciscus Verwiel , Brian Ocallaghan , Ernest Loumaye , Stephanie Brown , Shauna Dillon , Edward Mathers , Catarina Edfj , Santhera Pharmaceuticals , Genentech , Committee For The Fiscal Year , Edinburgh Business School , Compensation Committee , Swiss Exchange , University Of Edinburgh , Novartis , Management Inc , Public Accounting Firm , Mount Allison University , Office Contact , General Meeting , Chemin Des Aulx , Annual Report , Statutory Financial Statements , Consolidated Financial Statements , Fiscal Year , Executive Committee , Briano Callaghan , President North America , Biotechnology Innovation Organization , Operating Board , West Island Palliative Care Residence , Independent Registered Public Accounting , Rue De La Coulouvreni , Independent Representative , Share Capital , Conversion Shares , Warrant Shares , Securities Purchase , Nasdaq Listing Rules , Restated Securities Purchase Agreement , Nasdaq Global Select Market , Obseva , Nnual , Eneral , Meeting , 022 ,